|
PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies and innovative medical devices, sold worldwide through licensees and distributors. PH&T was founded in Milan in 1991 with the aim of selecting and developing niche products and selling them through firm commercial partnerships.
Our offer allows generic companies to complement their product portfolio with difficult-to-formulate, not top-selling pharmaceuticals. Over 30 professionals form PH&T team, working together for the success of the company, from pipeline selection to dossier registration and finished product supply.
|
|
 Exemestane PH&T proved bioequivalent to AromasinÒ (Pfizer)
December 2009 PH&T has developed Exemestane, the generic formulation of Aromasin® 25mg (Pfizer).
Recently PH&T conducted a bioequivalence study to characterize the pharmacokinetic profile of its formulation (Exemestane PH&T 25mg sugar coated tablets) relative to that of reference formulation (Aromasin® 25mg sugar coated tablets).
|
|
Read more...
|
|
PH&T and iNova Pharmaceutical Australia announce their agreement for RINAR
August 2009. PH&T has signed an exclusive license agreement with iNova Pharmaceuticals (Australia) for RINAR, its nasal spray device for the treatment of non-allergic rhinitis.
|
|
Read more...
|
|
|
